MedinCell
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 Rue Des Freres Lumiere, Jacou, Occitan...Phone Number
+33467021367Website
www.medincell.comRevenue
$22.4 MillionStock Symbol
MEDCLIndustry
About MedinCell
MedinCell is a clinical- and commercial-stage biopharmaceutical company headquartered in Montpellier, France, focused on developing long-acting injectable treatments across multiple therapeutic areas. Founded in 2003 and publicly traded on Euronext Paris, the company leverages its proprietary BEPO technology platform to enable controlled, sustained drug delivery over days, weeks, or months following a single subcutaneous or local injection using fully bioresorbable deposits. MedinCell's approach is designed to improve patient adherence, enhance treatment accessibility, and reduce the environmental impact of medicines. Its first FDA-approved product, UZEDY, is a risperidone-based long-acting injectable marketed by Teva Pharmaceuticals for schizophrenia and bipolar I disorder.Explore more
MedinCell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
MedinCell Tech Stack
A closer look at the technologies used by MedinCell
See more technologies
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding MedinCell
Sign Up For FreeTo access detailed company insights
MedinCell is a clinical- and commercial-stage biopharmaceutical company headquartered in Montpellier, France, focused on developing long-acting injectable treatments across multiple therapeutic areas. Founded in 2003 and publicly traded on Euronext Paris, the company leverages its proprietary BEPO technology platform to enable controlled, sustained... Read More
